Literature DB >> 10077479

Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.

A Gabizon1, A T Horowitz, D Goren, D Tzemach, F Mandelbaum-Shavit, M M Qazen, S Zalipsky.   

Abstract

Conjugates of three components, folic acid-poly(ethylene glycol)-distearoylphosphatidylethanolamine (FA-PEG-DSPE), derived from PEG with molecular masses of 2000 and 3350 Da were synthesized by a carbodiimide-mediated coupling of FA to H2N-PEG-DSPE. The conjugates were characterized by 1H NMR, MALDI-TOF, and HPLC analysis of enzymatic cleavage with carboxypeptidase G. As a prototype of a folate receptor (FR)-targeted system, the conjugates were formulated at 0.5 mol % phospholipid in hydrogenated phosphatidylcholine/cholesterol liposomes with or without additional methoxyPEG2000-DSPE. In vitro binding studies were performed with sublines of M109 (murine lung carcinoma) and KB (human epidermal carcinoma) cells each containing high and low densities of FR. FA-PEG-DSPE significantly enhanced liposome binding to tumor cells. The best binding was observed when FA-PEG liposomes contained no additional mPEG-lipid. In fact, our experiments showed that the presence of mPEG on liposomal surfaces significantly inhibited FA-PEG-liposome binding to FR. Increasing the molecular mass of the PEG tether from 2000 to 3350 Da improved the FR binding, particularly in the case of mPEG-coated liposomes. The FA-PEG liposomes bound to M109-HiFR cells very avidly as demonstrated by the inability of free FA (used in a 700-fold excess either at the beginning or at the end of the incubation) to prevent the cell binding. This is in contrast to the 5-10-fold lower cell binding activity of mPEG-FA compared to that of free FA, and likely to be related to the multivalent nature of the liposome-bound FA. Only 22% of FA-PEG3350 and 32% of FA-PEG3350/mPEG cell-associated liposomes could be removed by exposure to pH 3, conditions that dissociate FA-FR, suggesting that more than two-thirds of the bound liposomes were internalized during incubation for 24 h at 37 degrees C. FA-targeted liposomes also show enhanced nonspecific binding to extracellular tissue culture components, a phenomenon especially relevant in short incubation time experiments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077479     DOI: 10.1021/bc9801124

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  64 in total

1.  Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.

Authors:  Amir Fakhari; Abdulgader Baoum; Teruna J Siahaan; Khoi Ba Le; Cory Berkland
Journal:  J Pharm Sci       Date:  2010-10-04       Impact factor: 3.534

2.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.

Authors:  Lin Zhu; Pooja Kate; Vladimir P Torchilin
Journal:  ACS Nano       Date:  2012-03-14       Impact factor: 15.881

3.  In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery.

Authors:  Sumanta K Sahu; Sanjay K Mallick; Susmita Santra; Tapas K Maiti; Sudip K Ghosh; Panchanan Pramanik
Journal:  J Mater Sci Mater Med       Date:  2010-01-29       Impact factor: 3.896

4.  The role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces.

Authors:  Nathan W Moore; Tonya L Kuhl
Journal:  Biophys J       Date:  2006-06-02       Impact factor: 4.033

5.  Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applications.

Authors:  Mohiuddin A Quadir; Stephen W Morton; Lawrence B Mensah; Kevin Shopsowitz; Jeroen Dobbelaar; Nicole Effenberger; Paula T Hammond
Journal:  Nanomedicine       Date:  2017-03-02       Impact factor: 5.307

6.  In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer.

Authors:  Cristina Müller; P August Schubiger; Roger Schibli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-24       Impact factor: 9.236

7.  Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration.

Authors:  Kareen Riviere; Zhaohua Huang; Katherine Jerger; Nichole Macaraeg; Francis C Szoka
Journal:  J Drug Target       Date:  2010-03-30       Impact factor: 5.121

Review 8.  Antibody-based therapeutics for the treatment of human B cell malignancies.

Authors:  Sivasubramanian Baskar; Natarajan Muthusamy
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

9.  Synthesis, characterization, and in vitro assay of folic acid conjugates of 3'-azido-3'-deoxythymidine (AZT): toward targeted AZT based anticancer therapeutics.

Authors:  Anthony R Vortherms; Robert P Doyle; Dayuan Gao; Olivia Debrah; Patrick J Sinko
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-02       Impact factor: 1.381

10.  Gold nanorods mediated controlled release of doxorubicin: nano-needles for efficient drug delivery.

Authors:  Sunil Pandey; Ritu Shah; Ashmi Mewada; Mukeshchand Thakur; Goldie Oza; Madhuri Sharon
Journal:  J Mater Sci Mater Med       Date:  2013-03-23       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.